Last January 11th news didn't make the news wiresSo here it is ...
Vancouver, British Columbia, January 11, 2024 – Cognetivity Neurosciences Ltd. (“the Company” or “Cognetivity”) (CSE: CGN, OTCQB: CGNSF, FWB.1UB), a technology company that has created a unique Artificial Intelligence (AI) powered brain health screening and monitoring platform for use in medical, commercial and consumer environments, is delighted to announce that it has completed registration for its CognICATM cognitive assessment system with the Therapeutic Goods Administration of Australia under the Therapeutic Goods (Medical Devices) Regulations 2002, ARTG Identifier 429151. This registration allows the company to market the medical device commercially for clinical use in Australia.